APOB and hepatocellular carcinoma: The inactivation or low activity of apolipoprotein B (ApoB) is associated with poor prognosis of HCC, upregulation of oncogenic and metastatic factors, and the inhibition of tumor suppressor genes [101,102], such as p53 and phosphatase and tensin homolog (PTEN).